Skip to content

Effectiveness of a Personalized Home-Based Exercise Rehabilitation System for COPD patients:a randomized controlled trial

Effectiveness of a Personalized Home-Based Exercise Rehabilitation System for COPD patients:a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092393
Enrollment
Unknown
Registered
2024-11-15
Start date
2024-11-17
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pulmonary obstructive disease

Interventions

Intervention group:Patients in the intervention group use a home-based pulmonary rehabilitation system supported by a digital remote pulmonary rehabilitation intervention platform. The platform featur
Control group:Patients in the control group also use the home-based pulmonary rehabilitation system, but the exercise programs are chosen freely by the patients from the options available on the platf

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 40 and 80 years, male or female, with or without a history of smoking. 2.COPD patients who meet the inclusion criteria: FEV1/FVC < 70% measured 20 minutes after inhaling a bronchodilator (Salbutamol 400ug). 3.Have had an outpatient or inpatient visit due to acute exacerbation within the past month. 4.Patients are able to communicate verbally or in writing and are capable of completing auxiliary tests related to the study. 5.Approval from an ethics committee has been obtained, and informed consent from the patient has been acquired. 6.The patient or their family members can use a smartphone and are able to interact effectively with doctors via WeChat.

Exclusion criteria

Exclusion criteria: 1.Patients with consciousness impairment or psychiatric disorders. 2.Clinically diagnosed lung cancer, bronchiectasis, pneumoconiosis, or other purely restrictive ventilatory disorders. 3.Patients with hematologic diseases or malignancies affecting the completion of the study. 4.Active pulmonary tuberculosis at the time of enrollment. 5.Unstable heart disease or arrhythmias requiring pharmacological intervention. 6.Patients younger than 18 years of age. 7.Patients or their family members unwilling to participate. 8.Patients currently participating in other clinical trials

Design outcomes

Primary

MeasureTime frame
Maximal Inspiratory Pressure;Maximal Expiratory Pressure;Six-minute walk test ;Diaphragm Thickness;

Secondary

MeasureTime frame
Forced expiratory volume exhaled in the first second;Forced Vital Capacity;Diaphragm Thickening Fraction;Diaphragm Excursion;1-Minute Sit-to-Stand Test;30-Second Arm Curl Test;COPD Assessment Test;Modified Medical Research Council Dyspnea Scale;Hospital Anxiety and Depression Scale;Clinical COPD Questionnaire;Activities of Daily Living Scale;Mini Nutritional Assessment;Rehabilitation Cognition Scale;

Countries

China

Contacts

Public ContactJinliang Kong

The first affiliated hospital of Guangxi medical university

kjl071@126.com+86 139 7888 1546

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026